Jodi Muscal, MD

Jodi Muscal, MD is a board-certified pediatric hematologist-oncologist currently serving as a Medical Director in clinical development at Amgen where she is a clinical lead in the global blinatumomab program. Prior to joining Amgen, Jodi was a Pediatric Clinical Director at Pfizer in the Pediatric Center of Excellence and involved in the execution of global investigational drug trials in pediatric oncology, including palbociclib and gemtuzumab ozogamicin, and in developing the strategy for assets in pediatric development for hematologic and solid tumor malignancies.

Prior to joining industry, Jodi was an Associate Professor of Pediatrics at Baylor College of Medicine, served in multiple roles in the Children’s Oncology Group and other pediatric oncology consortia and primarily cared for patients with solid tumors and those in early phase trials. She is a graduate of Duke University, Temple University School of Medicine, the pediatric residency program at Children’s Hospital of Pittsburgh, and the pediatric hematology/oncology fellowship program at Texas Children’s Hospital/Baylor College of Medicine.